Please login to the form below
Coronavirus vaccine
This page shows the latest Coronavirus vaccine news and features for those working in and with pharma, biotech and healthcare.
Moderna says its COVID-19 vaccine appears effective against Delta and other variants
combines Moderna’s authorised vaccine against ancestral strain and mRNA-1273.351 in a single vaccine. ... These findings highlight the importance of continuing to vaccinate populations with an effective primary series vaccine,” he added.
Latest news
-
Study finds mixed vaccine schedules provide strong immune response against COVID-19
And AZ's Vaxzevria COVID-19 vaccine shows strong immune responses following a delayed second dose. ... the AstraZeneca/Oxford University vaccine followed by the Pfizer/BioNTech vaccine – provide good protection against COVID-19.
-
GSK and Medicago’s COVID-19 vaccine shows promising antibody responses in phase 2
The vaccine candidate combines Medicago’s recombinant coronavirus virus-like particles (CoVLP) with GSK’s pandemic adjuvant system. ... Earlier this week, GSK also announced positive mid-stage results for its Sanofi-partnered COVID-19 vaccine
-
Single dose of COVID-19 vaccines ‘significantly’ reduces infections
In addition, individuals who had received a second dose of the Pfizer/BioNTech vaccine saw their risk of infection cut by 90%. ... In this study, researchers identified a lower antibody response to a single dose of either vaccine in older individuals who
-
J&J halts manufacturing of COVID-19 at US plant after FDA warning
Johnson &Johnson (J&J) has halted manufacturing of its COVID-19 vaccine at a plant in the US after the Food and Drug Administration (FDA) identified ‘ certain conditions’ that could lead ... In a statement, the FDA announced that it recently
-
Moderna COVID-19 vaccine shortfall could affect UK supply
offering at least one dose of a COVID-19 vaccine to all adults by the end of July. ... The Moderna vaccine is the third jab to be rolled out in the UK.
Study finds mixed vaccine schedules provide strong immune response against COVID-19
GSK and Medicago’s COVID-19 vaccine shows promising antibody responses in phase 2
Single dose of COVID-19 vaccines ‘significantly’ reduces infections
J&J halts manufacturing of COVID-19 at US plant after FDA warning
Moderna COVID-19 vaccine shortfall could affect UK supply
More from news
Approximately 47 fully matching, plus 58 partially matching documents found.
Latest Intelligence
-
How will COVID-19 affect uptake of vaccinations against other diseases?
Coronavirus will be a blip on the horizon in comparison. The risk is trivial.”. ... Notably, Russia’s Sputnik V vaccine, developed by Moscow’s Gamaleya research centre, and announced by President Vladimir Putin in August as being the world’s
-
Multilingual remote conferencing and interpreting platforms in the era of COVID-19
The conference listings for 2020 were well established, but as the coronavirus became a more severe threat, the months of upfront planning were put on hold. ... In April this year there were 650 groups around the world carrying out 460 different
-
Developing a COVID-19 vaccine
GlaxoSmithKline has also partnered with Chinese biotech company Clover Biopharmaceuticals on a protein-based coronavirus vaccine candidate, named COVID-19 S-Trimer. ... Translate has already begun to produce multiple mRNA constructs and will use its
Multilingual remote conferencing and interpreting platforms in the era of COVID-19
Developing a COVID-19 vaccine
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
to use mRNA vaccine technology and among the first to use viral vectors,. ... The Independent. https://www.independent.co.uk/news/world/americas/coronavirus-vaccine-phase-3-covid-fda-cure-a9704111.html. Published 2020. Accessed May 26, 2021. 5. About the
-
Vaccine hesitancy eBook
Download the PDF to explore:. Original research findings on the deeper drivers behind vaccine hesitancy and the benefits of taking a human-centred approach for increasing vaccine uptake. ... The motivations behind the Arm in Arm campaign, a global
-
Blog - Vaccine Hesitant? It’s About What You Know and Who You Trust
a deep distrust of Government and the systems administering and communicating about the vaccine. ... the vaccines work, how safety is monitored, what new variants mean and, in the UK with at least 15m people having received at least one dose of a
-
Travel in the time of COVID
1. The vaccine roll out in the EU markets is proving to have a lot of grit in the system, from approvals and licensing, to pricing challenges, to logistics. ... The vaccine developers are staying on top of the mutant strains and getting just
-
Should diversity in clinical trials be mandatory?
In October 2020, of the 270, 000 people already recruited to coronavirus vaccine trials, only 7% were ethnic minorities.
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
Blog - Vaccine Hesitant? It’s About What You Know and Who You Trust
Travel in the time of COVID
Should diversity in clinical trials be mandatory?
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital project manager
-
Competitive
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Digital account director
-
Competitive
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
-
Digital strategist
-
Competitive
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- GSK reveals plans for £400m R&D facility expansion in England
- EU approves bluebird bio’s CALD gene therapy Skysona
- NHS earmarks £340m for new medicines fund to fast-track ‘innovative’ treatments
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- Onyx Health Launch Creative Studio After Record Year
- Kriya Therapeutics raises $100m to further develop gene therapies with ‘broader applications’
- Lilly and Banner Alzheimer’s Institute collaborate on donanemab prevention trial
- Positive prospects for pharma in Latin America
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Biosimilars in China
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
